JC
Jaideep Chatrabhuj Raigagla
About Jaideep Chatrabhuj Raigagla
Data last updated:
Jaideep Chatrabhuj Raigagla is a Director at Rosefinch Pharmaceutique Private Limited (since 2024), Director at Image Equity (India) Private Limited (since 1999) and Designated Partner at Bavla Real Estate Advisory Llp (since 2026), and holds 2 more current directorships. The companies operate in Pharma, Financial Services and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹6.64 Cr; the largest is Rosefinch Pharmaceutique Private Limited at ₹5.20 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 May 2024 | 2016 | ₹5.20 Cr (FY 2025) | Active | |
| Director | 23 Aug 1999 | 1999 | ₹1.43 Cr (FY 2024) | Active | |
| Designated Partner | 30 Jun 2026 | 2026 | Active | ||
| Designated Partner | 13 Jun 2025 | 2025 | Active | ||
| Designated Partner | 11 May 2018 | 2018 | Active |
Board colleagues of Jaideep Chatrabhuj Raigagla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhishek Chandrakant Rabara | 09718537 | Rosefinch Pharmaceutique Private Limited | Director |
| Aditya Hitendrakumar Bhatt | 08019178 | Rosefinch Pharmaceutique Private Limited | Director |
| Chetan Dalpatbhai Hansalia | 08189005 | Rosefinch Pharmaceutique Private Limited | Director |
| Chiragbhai Rameshbhai Paleja | 05221750 | Rosefinch Pharmaceutique Private Limited | Director |
| Mahesh Labhshankar Purohit | Rosefinch Pharmaceutique Private Limited | Company Secretary | |
| Milankumar Rashmikant Trivedi | 05256043 | Rosefinch Pharmaceutique Private Limited | Managing Director |
| Tejas Ashok Parekh | 07870836 | Rosefinch Pharmaceutique Private Limited | Director |
| Vijaybhai Arjanbhai Nagecha | 08188996 | Rosefinch Pharmaceutique Private Limited | Director |
| Kailash Pratap Mariwala | 00954054 | Image Equity (India) Private Limited | Director |
| Himanshu Singhal | 10524625 | Bavla Real Estate Advisory Llp | Designated Partner |
| Komal Jaideep Raigagla | 11152913 | Raigagla Corporation Llp | Designated Partner |
| Kantaram Ganpat Kasurde | 03641011 | Green Leaf Valley View Amenities Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jaideep Chatrabhuj Raigagla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jaideep Chatrabhuj Raigagla
Jaideep Chatrabhuj Raigagla currently holds 5 directorships: Rosefinch Pharmaceutique Private Limited (Director, since 24 May 2024, revenue ₹5.20 Cr (FY 2025)); Image Equity (India) Private Limited (Director, since 23 Aug 1999, revenue ₹1.43 Cr (FY 2024)); Bavla Real Estate Advisory Llp (Designated Partner, since 30 Jun 2026); Raigagla Corporation Llp (Designated Partner, since 13 Jun 2025); Green Leaf Valley View Amenities Llp (Designated Partner, since 11 May 2018).
Jaideep Chatrabhuj Raigagla was first appointed on 23 Aug 1999 as Director at Image Equity (India) Private Limited. The most recent appointment on record is 30 Jun 2026 at Bavla Real Estate Advisory Llp.
The 2 current companies of Jaideep Chatrabhuj Raigagla that report revenue have a combined latest revenue of ₹6.64 Cr: Rosefinch Pharmaceutique Private Limited ₹5.20 Cr (FY 2025); Image Equity (India) Private Limited ₹1.43 Cr (FY 2024).
The current boards of Jaideep Chatrabhuj Raigagla's companies include Abhishek Chandrakant Rabara (Rosefinch Pharmaceutique Private Limited), Aditya Hitendrakumar Bhatt (Rosefinch Pharmaceutique Private Limited), Chetan Dalpatbhai Hansalia (Rosefinch Pharmaceutique Private Limited), Chiragbhai Rameshbhai Paleja (Rosefinch Pharmaceutique Private Limited), Mahesh Labhshankar Purohit (Rosefinch Pharmaceutique Private Limited), Milankumar Rashmikant Trivedi (Rosefinch Pharmaceutique Private Limited), among others.